Fair balance in direct-to-consumer antidepressant print and television advertising, 1995-2007

Rosemary J. Avery, Matthew Eisenberg, Kosali I. Simon

Research output: Contribution to journalArticlepeer-review

Abstract

The authors evaluated fair balance in the presentation of risks and benefits in a large sample of direct-to-consumer advertising for prescription antidepressant medications appearing in magazines (1995-2006) and television (1999-2007) to assess how well they meet U.S. Food and Drug Administration guidelines. Using content analysis to capture relevant dimensions of the ads, results indicated that (a) considerably less attention is given to risks relative to benefits and (b) implicit ad content favors communication of drug benefits over risks, but that fair balance in direct-to-consumer ads has improved over time. The authors discuss policy implications and explore future research directions.

Original languageEnglish (US)
Pages (from-to)250-277
Number of pages28
JournalJournal of health communication
Volume17
Issue number3
DOIs
StatePublished - Mar 1 2012
Externally publishedYes

ASJC Scopus subject areas

  • Health(social science)
  • Communication
  • Public Health, Environmental and Occupational Health
  • Library and Information Sciences

Fingerprint Dive into the research topics of 'Fair balance in direct-to-consumer antidepressant print and television advertising, 1995-2007'. Together they form a unique fingerprint.

Cite this